Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_assertion type Assertion NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_head.
- NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_assertion description "[The patient was treated with an HD-CAV chemotherapy regimen (cyclophosphamide, doxorubicin, vincristine, ifosfamide, etoposide) and was free of tumor until 18 months later, at which time he developed multiple metastases in the lungs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_provenance.
- NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_assertion evidence source_evidence_literature NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_provenance.
- NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_assertion SIO_000772 10555010 NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_provenance.
- NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_assertion wasDerivedFrom befree-2016 NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_provenance.
- NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_assertion wasGeneratedBy ECO_0000203 NP267286.RA-ULA3dP6dwkIp6nQ1kNWstM1B3yivm3w0Bt9rElgP-g130_provenance.